Thus, antagonizing CXCR1/CXCR2 with reparixin has multiple beneficial effects on the lung pathologies caused by ATM-deficiency via decreasing TNF-α production and reducing neutrophil recruitment and activation. The gene discussed is ATM; the disease is hyperinsulinemic hypoglycemia, familial, 4.